Cargando…
Liposomal bupivacaine does not decrease postoperative opioid use or length of hospital stay in patients undergoing anterior cervical discectomy and fusion
BACKGROUND: Despite its widespread use, definitive data demonstrating the efficacy of liposomal bupivacaine (LB) is limited especially in patients undergoing anterior cervical discectomy and fusion (ACDF). Therefore, this investigation examined whether ACDF patients who received intra-operative LB (...
Autores principales: | Neufeld, Eric V., Ng, Terence, Schaffler, Benjamin C., Iturriaga, Cesar, Katz, Austen, Job, Alan, Petersen, Christopher, Perfetti, Dean, Verma, Rohit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547693/ https://www.ncbi.nlm.nih.gov/pubmed/36285100 http://dx.doi.org/10.21037/jss-22-34 |
Ejemplares similares
-
What is a better value for your time? Anterior cervical discectomy and fusion versus cervical disc arthroplasty
por: Katz, Austen David, et al.
Publicado: (2022) -
Factors affecting hospital length of stay following anterior cervical discectomy and fusion
por: Arnold, Paul M., et al.
Publicado: (2011) -
Intercostal nerve blockade with liposomal bupivacaine reduces length of stay after video assisted thoracic surgery (VATS) lobectomy
por: Banks, Kian, et al.
Publicado: (2022) -
Association of Liposomal Bupivacaine on Opioid Consumption in the Pediatric Alveolar Cleft Population
por: Crowley, Jiwon Sarah, et al.
Publicado: (2019) -
Liposomal bupivacaine reduces opioid requirements following Ravitch repair for pectus excavatum
por: Abbasi, Rania K., et al.
Publicado: (2023)